LYPTAMZ Trademark

Trademark Overview


On Thursday, September 3, 2020, a trademark application was filed for LYPTAMZ with the United States Patent and Trademark Office. The USPTO has given the LYPTAMZ trademark a serial number of 79296549. The federal status of this trademark filing is REGISTERED as of Tuesday, April 20, 2021. This trademark is owned by NOVARTIS AG. The LYPTAMZ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
lyptamz

General Information


Serial Number79296549
Word MarkLYPTAMZ
Filing DateThursday, September 3, 2020
Status700 - REGISTERED
Status DateTuesday, April 20, 2021
Registration Number6324975
Registration DateTuesday, April 20, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, June 6, 2021NOTIFICATION PROCESSED BY IB
Thursday, May 20, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 20, 2021FINAL DISPOSITION PROCESSED
Thursday, May 20, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Saturday, January 30, 2021NOTIFICATION PROCESSED BY IB
Wednesday, January 13, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 13, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 4, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, January 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Saturday, December 26, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, December 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 21, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 22, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB